These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29434732)

  • 1. Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Kim YW; Kwon JH; Nam SW; Jang JW; Jung HS; Shin YR; Park ES; Shim DJ
    Exp Ther Med; 2018 Feb; 15(2):1479-1483. PubMed ID: 29434732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
    Nam HC; Jang B; Song MJ
    World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute necrotizing pancreatitis as a fatal complication following DC Bead transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and review of the literature.
    Yamaguchi T; Seki T; Komemushi A; Suwa K; Tsuda R; Inokuchi R; Murata M; Yuki M; Harima Y; Okazaki K
    Mol Clin Oncol; 2018 Oct; 9(4):403-407. PubMed ID: 30214729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
    Woo HY; Heo J
    Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
    Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
    J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
    Wu B; Zhou J; Ling G; Zhu D; Long Q
    World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.
    Yu CY; Ou HY; Weng CC; Huang TL; Chen TY; Leung-Chit L; Hsu HW; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1045-8. PubMed ID: 27320552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.
    Baur J; Ritter CO; Germer CT; Klein I; Kickuth R; Steger U
    Hepat Med; 2016; 8():69-74. PubMed ID: 27382341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.
    Nishi M; Saeki I; Yamasaki T; Maeda M; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
    Hepatol Res; 2018 Mar; 48(4):329-332. PubMed ID: 29098752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
    Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
    Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
    [No Abstract]   [Full Text] [Related]  

  • 11. DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study.
    Song DS; Choi JY; Yoo SH; Kim HY; Song MJ; Bae SH; Yoon SK; Chun HJ; Choi BG; Lee HG
    Gut Liver; 2013 Jan; 7(1):89-95. PubMed ID: 23424047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric and duodenal ischaemia after transarterial chemoembolisation for hepatocellular carcinoma: an unexpected but significant complication.
    Chintalapati SP; Patel A; Conjeevaram H
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29467124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic impact of transarterial chemoembolization with drug eluting beads in the treatment of hepatocellular carcinoma].
    Malbranche C; Boulin M; Guiu B; Pernot C; Cercueil JP; Serge Aho L; Musat A; Bedenne L; Hillon P; Guignard MH; Fagnoni P
    Bull Cancer; 2011 Jun; 98(6):671-8. PubMed ID: 21642049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional
    Song JE; Kim DY
    World J Hepatol; 2017 Jun; 9(18):808-814. PubMed ID: 28706579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Huang K; Zhou Q; Wang R; Cheng D; Ma Y
    J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma.
    Arabi M; BenMousa A; Bzeizi K; Garad F; Ahmed I; Al-Otaibi M
    Saudi J Gastroenterol; 2015; 21(3):175-80. PubMed ID: 26021777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Toro A; Bertino G; Arcerito MC; Mannnino M; Ardiri A; Patane' D; Di Carlo I
    Case Rep Surg; 2015; 2015():873601. PubMed ID: 25802793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol.
    Recchia F; Passalacqua G; Filauri P; Doddi M; Boscarato P; Candeloro G; Necozione S; Desideri G; Rea S
    Oncol Rep; 2012 May; 27(5):1377-83. PubMed ID: 22294036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.